Mid-Cap Pharma: Wockhardt jump starts sales 42%

The run of luck for the company has changed finally after restructuring and FCCB woes were mostly disposed off as the medicine major brought back 43% jump in sales to INR14.3B and has doubled profits from INR 1.94 Bln odd to INR3.8B, despite RM casts having jumped from 24B to 41B

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s